Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....
Strategic move aims to accelerate advancements in cancer detection and drug development....
Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....
The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments. This burgeoning industry is poised for significant growth, driven by a convergence of regional and global trends. As the region continues to embrace innovation and prioritise healthcare, it is well on its way to becoming a global hub for medtech and diagnostics, attracting investment, fostering collaboration, and driving advanc...
Asia accounts for nearly half of global cancer cases, making it a major health concern. Recognising the promise of precision oncology, governments across the region have initiated efforts to drive advancements in this space. Let's take a closer look at the progress being made in precision oncology in the Asia Pacific region....
The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities....
JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....
A graduate of CDL-Seattle, Diag-Nose.io aims to enhance respiratory disease diagnosis and treatment through advanced AI-driven solutions....
The strategic acquisition enhances Telix’s next-generation radiopharmaceutical capabilities, strengthening its position in precision oncology and beyond....
The latest updates on the market rollout of Ryoncil® and insights into the company’s expanding pipeline of innovative therapies....
